Detalhe da pesquisa
1.
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
Cancer
; 129(21): 3381-3389, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395170
2.
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
Cancer
; 127(23): 4447-4454, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379792
3.
Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Front Oncol
; 11: 666691, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912470
4.
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
Oncologist
; 15(12): 1310-9, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148613
5.
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.
J Clin Oncol
; 34(23): 2736-42, 2016 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27382098